A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants
Clinical trial NCT06740474 · COMPLETED
Trial details
- NCT number
- NCT06740474
- Sponsor
- Assembly Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-31
- Primary completion
- 2025-07-08
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.